DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab
DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab
Active, not recruiting · NCT03688178 · Registry updated 2026-05-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| DC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Phase 2 | 2026-05-22 | NCT03688178 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Annick Desjardins, MD | 1 |
| Celldex Therapeutics | 13 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Duke University Medical Center | Durham | United States | 505 |